Anumio Program
Companion Animal Health (Various)
PreclinicalActive
Key Facts
About Frenelle Pharma
Frenelle Pharma is a private, platform-based biotech company developing and commercializing its Faros™ long-acting injectable drug delivery technology. The company operates a unique business model of creating focused subsidiary ventures—SpineThera (Phase 2 for sciatica), Frenelle PBC (substance use disorders), and Anumio (animal health)—to advance programs from discovery to commercialization. With over a decade of R&D investment, proven preclinical data, and an active Phase 2 asset, Frenelle is positioned to disrupt markets in pain management, addiction, and veterinary medicine through improved therapeutic delivery.
View full company profile